It is reported that aberrant methylation can lead to pancreatic cancer, and overexpression of DNMT1 may be a crucial factor leading to the increased DNA methylation in cancer cells, resulting in abnormal activation of transcription and inhibition of protein degradation. The gene discussed is DNMT1; the disease is pancreatic neoplasm.